Retatrutide is primarily being developed for obesity treatment, with TRIUMPH trials focusing on weight loss in people with and without diabetes
As dietary components, these polyols may play a significant role in modulating gut hormone secretion, which is crucial for appetite control and energy homeostasis
Patients taking medicines with narrow therapeutic windows such as certain anticoagulants, thyroid hormones, or immunosuppressants should discuss timing with their trial clinician to ensure consistent drug absorption and appropriate monitoring
India GLP-1 Receptor Agonists Obesity Drugs Market Insight The India GLP-1 receptor agonists obesity drugs accounted for the largest revenue share in Asia Pacific in 2024, driven by a growing obesity burden, increasing healthcare awareness, and the rapid expansion of urban healthcare infrastructure
doi: 10.17113/ftb.57.01.19.5865 17 IsmayaW